UGT1A6 and UGT2B7 Gene Polymorphism and its Effect in Pediatric Epileptic Patients on Sodium Valproate Monotherapy

被引：0
|
作者：
P. B. Nandith
Usha Adiga
Vijaya Shenoy
Sachidananda Adiga M N
机构：
[1] Research Scholar,
[2] K S Hegde Medical Academy,undefined
[3] Nitte (Deemed to be University),undefined
[4] Department of Pharmacology,undefined
[5] Pediatrics & Biochemistry,undefined
[6] K S Hegde Medical Academy,undefined
[7] Nitte (Deemed to be University),undefined
来源：
Indian Journal of Pediatrics | 2021年 / 88卷
关键词：
Pediatric epilepsy; Genetic polymorphism; Sodium valproate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：764 / 770
页数：6
相关论文
共 50 条
  • [21] Identification of micrornas involved in the regulation of human UGT1A, UGT2B7 and UGT2B15 gene expression
    Papageorgiou, John
    Court, Michael H.
    DRUG METABOLISM REVIEWS, 2016, 48 : 25 - 26
  • [22] Effect of UGT1A4, UGT2B7, UGT2B15, UGT2B17 and ABC1B polymorphisms on lamotrigine metabolism in Danish patients
    Petrenaite, Vaiva
    Ohman, Inger
    Jantzen, Frederik Peter Thal
    Ekstrom, Lena
    EPILEPSY RESEARCH, 2022, 182
  • [23] THE EFFECT OF UGT1A6 POLYMORPHISM AT TWO LOCI ON THE CLINICAL RESPONSE TO VALPROIC ACID IN EPILEPTIC CHILDREN
    Algharably, E. A.
    El Hamamsy, M.
    Hassanein, S. M.
    Mohamed, N. A.
    Mahran, M. Z.
    El-Sawy, M. A.
    Badary, O. A.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (10): : 3986 - 3994
  • [24] Isolation and characterization of the human UGT2B7 gene
    Carrier, JS
    Turgeon, D
    Journault, K
    Hum, DW
    Bélanger, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 272 (02) : 616 - 621
  • [25] Effects of UGT1A6, UGT2B7, and CYP2C9 Genotypes on Plasma Concentrations of Valproic Acid in Chinese Children with Epilepsy
    Guo, Yingjie
    Hu, Cheng
    He, Xiaojing
    Qiu, Feng
    Zhao, Limei
    DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (05) : 536 - 542
  • [26] Involvement of human hepatic UGT1A1, UGT2B4, and UGT2B7 in the glucuronidation of carvedilol
    Ohno, A
    Saito, Y
    Hanioka, N
    Jinno, H
    Saeki, M
    Ando, M
    Ozawa, S
    Sawada, J
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (02) : 235 - 239
  • [27] The Effect of UGT2B7*2 Polymorphism on the Pharmacokinetics of OROS® Hydromorphone in Taiwanese Subjects
    Vandenbossche, Joris
    Richards, Henry
    Francke, Stephan
    Van Den Bergh, An
    Lu, Chih Cherng
    Franc, Monique A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (10): : 1170 - 1179
  • [28] Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells
    Münzel, PA
    Schmohl, S
    Heel, H
    Kälberer, K
    Bock-Hennig, BS
    Bock, KW
    DRUG METABOLISM AND DISPOSITION, 1999, 27 (05) : 569 - 573
  • [29] Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7-161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children
    Liu, Limin
    Zhao, Limei
    Wang, Qiuning
    Qiu, Feng
    Wu, Xiujun
    Ma, Yanan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (11) : 1341 - 1347
  • [30] The Inhibitory Effect of 20(S)-Protopanaxatriol (ppt) Towards UGT1A1 and UGT2B7
    He, Ya-Jun
    Fang, Zhong-Ze
    Ge, Guang-Bo
    Jiang, Peng
    Jin, Hui-Zi
    Zhang, Wei-Dong
    Yang, Ling
    PHYTOTHERAPY RESEARCH, 2013, 27 (04) : 628 - 632
12345